Dr. Mahoney on Potential of VISTA-Targeting Therapy in RCCByKathleen Mahoney, MD, PhDOctober 23rd 2019Kathleen Mahoney, MD, PhD, discusses the potential of targeting V-domain immunoglobulin containing suppressor of T-cell activation in renal cell carcinoma.